Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208916 · ClinicalTrials.gov registry record · NA
Evaluation of the Potential of Grape Consumption to Improve Muscle Strength and Cognitive Function
A NA study of Healthy, sponsored by Western New England University.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT07208916: Recruiting NA study of Healthy, sponsored by Western New England University.
NCT07208916 is a NA study of Healthy that is actively recruiting participants, run by Western New England University. The registered enrollment target is 35 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07208916, a NA study of Healthy, is actively recruiting participants, sponsored by Western New England University.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if eating grapes can improve muscle strength and thinking in generally healthy women over 65. The main questions it aims to answer are: Does eating grapes improve muscle strength in women over 65? Does eating grapes improve cognition in women over 65? Participants will be asked to take part in 4 sessions on campus. Each session will include: Functional muscle strength testing Cognitive testing Blood draws
Primary Outcome
Through serum analysis, myostatin will be measured in units of pg/mL at three points throughout the study.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Grape Powder
Study Locations (1)
Massachusetts
- Western New England University - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-09-09 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT07208916 shows while recruiting
NCT07208916 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Grape Powder is the first listed.
NCT07208916 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07208916 about?
NCT07208916 is a clinical study titled "Evaluation of the Potential of Grape Consumption to Improve Muscle Strength and Cognitive Function". The goal of this clinical trial is to learn if eating grapes can improve muscle strength and thinking in generally healthy women over 65. The main questions it aims to answer are: Does eating grapes improve muscle strength in women over 65? Does eating grapes improve cognition in women over 65? Pa...
What is the current status of trial NCT07208916?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-09-09. Estimated completion is 2026-04-30.
What conditions does trial NCT07208916 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT07208916?
The interventions under investigation include: Grape Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07208916?
This trial is sponsored by Western New England University, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208916 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07208916's enrollment target sits among peer trials
35 623rd of 1090 higher than 461 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI